NSEAnalysts/Institutional Investor Meet/Con. Call Updates9h ago · 18 Nov 2026, 11:01 pm

Analysts/Institutional Investor Meet/Con. Call Updates

NGL Fine-Chem Limited · NGLFINE

✦ AI SummaryResults

NGL Fine-Chem Limited has informed the Exchange about the transcript of the Earnings Conference Call for Q2 & H1 FY 27 held on November 12, 2026.

Analysis Scores

Earnings Impact8/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

NGL Fine-Chem Limited has informed the Exchange about Transcript

Attachments (1)

📄

NGL2022_18112026230116_Outcome_Investors_Transcript_Signed.pdf

pdf

Download →
View document text
November 18, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, 5th Floor, Plot No.C/1, G Block, Dalal Street, Fort, Bandra Kurla Complex, Bandra East, Mumbai 400 001. Mumbai 400051. Scrip Code: 524774 Symbol: NGLFINE Dear Sir/Madam, Sub: Transcript of the Earnings Call – Q2 & H1 FY 27. Dear Sir/Madam, Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the Transcript of the Earnings Conference Call for Q2 & H1 FY 27 held on Thursday, November 12, 2026. The above transcript is also being made available under the Investors Section on the Company’s website at www.nglfinechem.com . You are requested to kindly take the information on record. Thanking you, Yours faithfully, For NGL Fine-Chem Limited Shivam Gharat Company Secretary and Compliance Officer M. No.: A56704 Encl: As Above. “NGL Fine-Chem Limited Q2 & H1 FY’27 Earnings Conference Call” November 12, 2026 MANAGEMENT: MR. RAHUL NACHANE MANAGING DIRECTOR NGL FINE-CHEM LIMITED MR. RAJESH LAWANDE WHOLE-TIME DIRECTOR & CFO NGL FINE-CHEM LIMITED Page 1 of 16 NGL Fine-Chem Limited November 12, 2026 NGL Fine-Chem Limited Q2 and H1 FY27 Earnings Conference Call November 12, 2026 Disclaimer: This transcript has been prepared from the audio recording of the Earnings Conference Call held on November 12, 2026, and has been edited for clarity, readability and grammatical accuracy. Verbal fillers, repetitions and obvious transcription errors have been removed wherever necessary. Such editorial changes are not intended to alter the substance or meaning of the discussions. While every effort has been made to ensure accuracy, the transcript may not be a verbatim reproduction of the proceedings. In case of discrepancy, the audio recordings will prevail. Moderator: Ladies and gentlemen, good day and welcome to the Q2 and H1 FY27 Earnings Conference Call of NGL Fine-Chem Limited. As a reminder, all participant lines will be in listen-only mode, and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during the conference call, please signal an operator by pressing ‘*’ followed by ‘0’ on your touchtone phone. Please note that this conference is being recorded. I now hand the conference over to Mr. Abhishek Mehra from TIL Advisors. Thank you and over to you, Abhishek. Abhishek Mehra: Thank you, Danish. Good morning, everyone, and thank you for joining this Q2 and H1 FY27 Earnings Conference Call of NGL Fine-Chem Limited. The results and investor updates have been uploaded to the stock exchanges. To take us through the results for the quarter and answer your questions, we have with us today Mr. Rahul Nachane, Managing Director, and Mr. Rajesh Lawande, Whole-Time Director and Chief Financial Officer. We will start the call with a brief overview of the financial performance, followed by the Q&A session. I would like to remind you that any statements made on this call that reflect an outlook for the future and may be construed as forward-looking statements must be viewed in conjunction with the uncertainties and risks that the company faces. These uncertainties and risks include, but are not limited to, those mentioned in our annual reports. With that, I will now hand over the call to Mr. Rahul Nachane. Over to you, sir. Page 2 of 16 NGL Fine-Chem Limited November 12, 2026 Rahul Nachane: Good morning, everyone, and welcome to NGL Fine-Chem Limited's Q2 and H1 FY27 earnings call. Thank you for joining us and for reviewing our financial results and investor presentation. Q2 was a strong quarter for NGL with higher revenues, improved operating profitability, and continued volume growth. We also commenced production in Phase II of our Tarapur greenfield facility on 24 September 2026, completing the commissioning of the project. These developments give us greater confidence in the business. At the same time, commissioning marks the beginning of the next stage: building utilization, completing customer and regulatory requirements, and earning an appropriate return on the investment. Let me first take you through our consolidated financial performance. Revenue from operations for Q2 FY27 was Rs. 158.71 crores, an increase of 32% over the corresponding quarter last year and 14% over Q1 FY27. Revenue also exceeded the Rs. 149.23 crores reported in Q4 FY26. Growth continued to be led primarily by volumes, supported by demand across our product portfolio and markets. EBITDA increased by 64% year-on-year to Rs. 28.06 crores. The EBITDA margin was 17.68%, compared with 14.27% a year earlier and 16.73% in the preceding quarter. The improvement reflects the benefit of partial price pass- through to customers in Q1 and better absorption of fixed costs at higher volumes. The quarter's margin was within the 15%-18% range we had indicated earlier. We are encouraged by this performance while recognizing that the cost of bringing new capacity into operation will influence margins over the coming quarters. Profit before tax was Rs. 21.60 crores, an increase of 67% year-on-year. Profit after tax increased by 69% to Rs. 16.25 crores. On a sequential basis, profit after tax was lower than the Rs. 18.4 crores reported in Q1. This should be viewed alongside the change in other income, which declined from Rs. 7.43 crores to Rs. 1.20 crores, and the increase in depreciation from Rs. 5.25 crores to Rs. 6.55 crores. Q1 had also benefited from inventory gains and favorable foreign exchange movements, as discussed in our previous update. At the operating level, Q2 EBITDA increased by approximately 20% over Q1. The underlying improvement in the business is therefore stronger than the sequential movement in reported net profit alone would suggest. In the first half, revenue from operations was Rs. 297.87 crores, an increase of Page 3 of 16 NGL Fine-Chem Limited November 12, 2026 approximately 33% over H1 FY26. Profit after tax was Rs. 34.64 crores compared with Rs. 18.87 crores in the corresponding period last year. Turning to cash flow and the balance sheet, net cash from operating activities was Rs. 35.80 crores in the first half. Net investing outflows were Rs. 44.05 crores as we continued expenditure towards completing the expansion. Inventories increased from Rs. 70.28 crores at the end of March to Rs. 118.38 crores at the end of September. This reflects higher business activity and the stock required to support the new facility and our sales growth. Nevertheless, the increase is significant, and working capital discipline will be an important priority as production and sales scale up. Total borrowings were approximately Rs. 122 crores, compared with Rs. 108 crores at the end of FY26. Our focus now is on converting the investment in capacity and working capital into sales, operating cash flow and improved results. Coming to Tarapur, Phase II is operational and fully staffed. The facility provides flexibility to manufacture existing products and support products in our development pipeline. In the near term, we intend to use the capacity to serve demand in our existing markets while progressing the requirements for business in regulated markets. We currently expect utilization to reach approximately 30%- 40% over the next two to three quarters, subject to customer demand, product mix and the pace of production ramp-up. As utilization builds, the facility's fixed operating costs will spread over a larger production base. Initially, however, these costs will be incurred ahead of the full revenue contribution. Depreciation and finance costs will also affect reported earnings as the project moves fully into operation. We therefore expect some pressure on margins during this transition. Higher volumes should support earnings over time, but the pace of improvement will depend on utilization, realizations and operating efficiency. Our regulatory program continues in parallel. I [Showing first 8,000 characters — download PDF for full document]